中国生化药物杂志2017,Vol.37Issue(9) :382-383,386.DOI:10.3969/j.issn.1005-1678.2017.09.170

糖尿病性胃轻瘫患者的降糖药物的合理使用

Reasonable use of hypoglycemic agents in patients with diabetic gastroparesis

刘潇 陶东红
中国生化药物杂志2017,Vol.37Issue(9) :382-383,386.DOI:10.3969/j.issn.1005-1678.2017.09.170

糖尿病性胃轻瘫患者的降糖药物的合理使用

Reasonable use of hypoglycemic agents in patients with diabetic gastroparesis

刘潇 1陶东红2
扫码查看

作者信息

  • 1. 青海省人民院 药学部,青海 西宁 810007
  • 2. 青海省西宁市第一人民医院 临床药学科,青海 西宁 810000
  • 折叠

摘要

目的 探讨胃轻瘫患者降糖药物的应用合理性.方法 分析胃轻瘫发病机制,并对常用降糖药物作用机制、适应证、不良反应及禁忌证等进行研究.结果 胃轻瘫降糖治疗药物类型较多,其作用机制及适用人群存在明显差异,根据患者病情特征、机体状况等选用适宜药物可改善临床疗效、保证用药安全性.结论 胃轻瘫发病机制较复杂,临床实际应根据患者发病原因、机体功能状态制定降糖药物治疗方案.

Abstract

Objective To study the rationality of hypoglycemic drugs in patients with gastroparesis. Methods The mechanism of gastroparesis was analyzed, and the mechanism, indications, adverse reactions and contraindications of common hypoglycemic agents were studied. Results There were significant differences in the mechanism of gastric hypoglycemia and hypoglycemic therapy. The mechanism of action and the application of the patients were obvious. According to the characteristics of the patients, the selection of the appropriate drugs could improve the clinical curative effect and ensure the safety of the drug. Conclusion The pathogenesis of gastroparesis is more complicated. The clinical practice should be based on the pathogenesis of the patients and the hypoglycemic drug regimen.

关键词

胃轻瘫/降糖药物/发病机制/用药合理性

Key words

gastric paralysis/hypoglycemic drugs/pathogenesis/rational drug use

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量1
参考文献量9
段落导航相关论文